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The internal capsid protein VI mediates adenovirus (AdV) endosome penetration during cell entry.
Essential to this process is the release of protein VI from the AdV capsid and subsequent membrane
targeting and insertion by the liberated VI molecules within the endocytic vesicle. In this study, we
describe a human AdV (HAdV) substitution mutant (AdV VI-G48C) within the critical N-terminal
amphipathic a-helical domain of protein VI. The VI-G48C virus displays altered capsid stability that
impacts protein VI release, membrane disruption and virus infectivity. This is due in part to aberrant
disulﬁde-bonding of protein VI molecules within the AdV particle. Our results provide insight into the
structural organization of protein VI in the virus particle, as well as highlight the role of protein VI in
cell entry.
& 2012 Elsevier Inc. All rights reserved.Introduction
Nonenveloped virus (NEV) cell entry is a highly coordinated
process that generally involves receptor binding, particle internaliza-
tion, escape to the cytosol, and in some cases, subcellular trafﬁcking
to the nucleus. A critical step in this pathway is penetration of the
limiting cellular membrane (i.e. plasma membrane, endosome, ER)
to allow the viral genome access to the cell replication machinery.
Generally, NEVs navigate this entry event via deployment of a
previously shielded membrane lytic factor in response to speciﬁc
host cell triggers (Tsai, 2007). Several different structural and func-
tional classes of NEV lytic agents have been described and they have
been shown to form pores or cause a gross rearrangement/disruption
of the limiting cell membrane (Moyer and Nemerow, 2011).
For HAdV, the cell entry process is initiated via binding of the
external ﬁber protein to a number of serotype-speciﬁc cellular
receptors (reviewed in Sharma et al., 2009), followed by second-
ary engagement of the penton base with cell surface integrins
(Wickham et al., 1993). Co-receptor engagement triggers the ﬁrst
of a series of disassembly steps within the AdV particle and
is followed by uptake into clathrin-coated vesicles (Burckhardt
et al., 2011; Lindert et al., 2009; Nakano et al., 2000). Once in the
endocytic pathway, the low pH environment (Seth et al., 1984)
is thought to further rearrange and dismantle the AdV capsid
and results in release of the membrane-lytic internal protein VI
(Greber et al., 1993; Wiethoff et al., 2005).ll rights reserved.
erow).Protein VI is initially expressed as a 250 amino acid precursor
(pVI) that is cleaved by the AdV-encoded protease at both the N- and
C-termini, generating the mature protein VI (residues 34–239). In
addition to its role in endosome lysis, protein VI has other functions in
the AdV life cycle. At late stages of replication, protein VI chaperones
hexon from the cytoplasm to the nucleus to facilitate particle
assembly (Wodrich et al., 2003). A C-terminal peptide cleaved from
pVI aids in capsid maturation, increasing AdV protease processivity
by functioning as a co-factor (Mangel et al., 1993). During cell entry,
VI also assists in AdV nuclear transport via microtubules (Wodrich
et al., 2010). Though the precise structural location of the 360
copies of protein VI within the AdV capsid (Lehmberg et al., 1999; van
Oostrum and Burnett, 1985) remains to be deﬁned, this capsid
molecule is thought to function as a cement protein, providing
increased stability to the particle shell (Liu et al., 2010; Reddy et al.,
2010; Saban et al., 2006; Stewart et al., 1993; van Oostrum and
Burnett, 1985).
The membrane lytic activity of protein VI is largely dependent
upon a well-conserved N-terminal amphipathic a-helical domain
(Fig. 1). Deletion of this region essentially abolishes membrane
lytic activity by recombinant protein VI (Wiethoff et al., 2005).
The current model for VI-mediated membrane lysis involves the
planar insertion of the hydrophobic face of the helix into the
target membrane, resulting in induction of positive curvature and
ultimately large-scale membrane disruption (Maier et al., 2010).
We have recently described a panel of randomly generated
AdV mutants within the amphipathic helical domain (Moyer et al.,
2011). The study focused primarily on a single AdV protein VI point
mutant (L40Q) that exhibited signiﬁcant reductions in infectivity and
endosome penetration. We now have systematically characterized
C.L. Moyer, G.R. Nemerow / Virology 428 (2012) 41–4742a unique mutant from this panel, AdV VI-G48C (Fig. 1), which is also
attenuated for infectivity and membrane disruption, albeit in a
mechanistically distinct manner. The G48C mutation induces forma-
tion of disulﬁde-bonded dimers of protein VI within the AdV particle,
altering capsid stability and protein VI exposure. This mutant reveals
the likely oligomeric organization of protein VI within the virion
and highlights the importance of protein VI in AdV infectivity and
membrane disruption.
Results
The G48C mutation impairs virus infectivity
We previously described a method for generating recombinant
adenoviruses with mutations in the protein VI amphipathic a-helicalFig. 1. Protein VI amphipathic a-helix. (Above) Residues 34–54 of the N-terminal
amphipathic a-helix are shown as a linear sequence, with position 48 highlighted
in bold face for the wild type and G48C proteins. (Below) The amphipathic a-helix
is depicted as a helical wheel projection. Residue G48 is marked with an
asterisk. Amino acids are shaded as follows: hydrophobic—black, polar—white,
basic—gray.
Fig. 2. Infectivity of the VI-G48C mutant virus. (A) A549 cells were infected with seria
with a Typhoon Fluorimager. The geometric mean ﬂuorescence (GMF)7SEM for tripl
overlaid with Avicel. After 72 h, the plates were imaged and the number of plaque
triplicate wells.domain (Moyer et al., 2011). In this study, we investigated a unique
mutation in protein VI (G48C) that impacts virus cell entry and
infection. We ﬁrst compared wild type and a previously character-
ized L40Q mutant, with AdV VI-G48C in a single-round infection
assay as measured by gene delivery. All viruses showed a dose-
dependent increase in infection as a function of input particles/cell
(p/c) (Fig. 2A). We used the data from this experiment to calculate
ID50 values for each virus and found that the G48C mutant required
3-fold higher p/c than wild type AdV to achieve the same level of
infection. The decrease in infectivity for the G48C mutant was not as
drastic as that of the AdV VI-L40Q virus, which was 12-fold reduced
compared to wild type virus. Nonetheless, the phenotype of the
G48C mutation is distinct from that of L40Q, as described below.
We further assayed infectivity of the G48C mutant in an AdV
plaque assay that measures viral replication, and show that the
mutant generated 3-fold less plaques than wild type AdV at 0.5 p/c
(Fig. 2B), in good agreement with the data from the single-round
infection (Fig. 2A). The L40Q virus was also reduced 13-fold in this
assay. Taken together, the results of these assays clearly indicate that
the AdV VI-G48C mutant impairs virus infectivity.Protein VI harboring the G48C mutation forms a dimer in the virus
particle
To better understand why the G48C mutation negatively
impacts infectivity, we ﬁrst analyzed the protein composition of
puriﬁed G48C mutant virus via SDS-PAGE under reducing condi-
tions. Using gel densitometry, we observed no change in the total
amount of protein VI incorporated into G48C particles when
compared to wild type AdV (data not shown). In addition, we
noted that pVI was fully cleaved to mature VI, suggesting that the
G48C mutant VI retained the ability to act as a co-factor for the
AdV protease (Mangel et al., 1993; Webster et al., 1993) and that
capsid maturation proceeded normally.
However, the G48C mutation could affect the structural
organization of protein VI within the capsid. In particular, the
introduction of a cysteine residue in the VI molecule could cause
disulﬁde bond formation with closely apposed protein VI mole-
cules or with other capsid proteins within the virus particle.
Therefore, we analyzed puriﬁed virus by SDS-PAGE and immuno-
blot for protein VI under reducing and non-reducing conditions
(Fig. 3A). Wild type AdV showed a single band corresponding to
monomeric protein VI (migrates as 27 kDa) in samples treated
with or without DTT. In contrast, protein VI from the G48C virus
migrated as two distinct bands, corresponding to the expected
molecular weights of a monomer and dimer (54 kDa) in thel dilutions of the AdVs indicated. Infection (GFP expression) was measured 48 h pi
icate samples is plotted. (B) 293b5 cells were infected with 0.5 particles/cell and
s/well was quantiﬁed. Data are the mean number of plaques/well7SEM from
Fig. 4. Thermostability of AdV particles containing the G48C mutation. AdV was
incubated at the indicated temperatures and the heat-disrupted particles were
subjected to density gradient ultracentrifugation to separate core-associated
(band) and released (sup) proteins as described in the Methods. Fiber and protein
VI were visualized via immunoblot.
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completely converted protein VI to monomeric form. Using
similarly prepared samples and gel densitometry analysis, we
calculated the ratio of monomer:dimer to be approximately 1:1.4
(data not shown). From these analyses, we conclude that the
G48C mutation enables a signiﬁcant portion of the protein VI
molecules to form homodimers within the virus particle.
To more fully explore the consequences of dimer formation on
protein VI functions, we engineered the G48C mutation into the
protein VI coding region comprised of residues 34–114 in a
bacterial expression vector (VI114). The membrane lytic activity
of this truncated form of protein VI is nearly identical to the full-
length version of the protein (Maier et al., 2010). SDS-PAGE
analysis of puriﬁed VI114 protein variants revealed that the
G48C mutant migrated as a mixture of monomer and dimer
under non-reducing conditions, while wild type and L40Q were
strictly monomeric (Fig. 3B). As with the G48C virus, treatment of
VI114-G48C with DTT converted all the protein VI to a monomeric
species, demonstrating the dependence of this dimerization on
intermolecular disulﬁde bonding. As expected, the L40Q mutant
protein VI did not exhibit dimerization.
The G48C mutation alters capsid stability and restricts protein VI
release
Release of protein VI from the interior of the HAdV capsid
during cell entry is a critical step in productive infection (Greber
et al., 1996; Smith and Nemerow, 2008). Therefore, we reasonedFig. 3. Protein VI molecules are disulﬁde-linked in VI-G48C particles and puriﬁed
protein. (A) Puriﬁed wild type or VI-G48C AdV were boiled in SDS sample
buffer72 mM DTT and analyzed by SDS-PAGE and western blot for protein VI.
(B) afﬁnity-puriﬁed recombinant VI114 proteins were boiled in SDS sample
buffer72 mM DTT, loaded on SDS-PAGE gels, and visualized with Simply Blue
staining. Dimer (D) and monomer bands (M) are indicated in both panels.that dimerization of protein VI via disulﬁde bond formation
within the virus particle could alter proper VI release from the
capsid in the cell endosome. To test this hypothesis, we employed
a well-characterized AdV thermostability assay designed to
mimic AdV endosomal uncoating. Two AdV proteins, ﬁber and
VI, were used as indicators of capsid dissociation following
heating. Fiber protein, located on the exterior of the capsid at
the ﬁve-fold vertices, is one of the ﬁrst proteins to be released
during cell entry. We observed that for both the wild type and
G48C virions, ﬁber was released between 45 and 50 1C (Fig. 4).
However, the pattern of protein VI release differed markedly
between the wild type and G48C mutant. Protein VI release for
the wild type virus paralleled ﬁber release, with full dissociation
occurring between 45 and 50 1C. In contrast, protein VI from the
G48C mutant was only partially liberated from the capsid at
the same temperature range, while a signiﬁcant portion (50%)
of the protein remained associated with the core even up to
temperatures as high as 60 1C. These ﬁndings suggest that the
release of G48C protein VI molecules from the capsid is more
restricted than the WT protein, perhaps due to increased capsid
stability, a situation that would impair endosome disruption and
subsequent infection.
The G48C mutation alters VI membrane lytic activity
In order to directly examine whether the G48C mutation alters
protein VI membrane lytic activity, we used an in vitro assay to
assess protein VI-mediated liposome disruption mediated by
heat-disassembled virions. A clear dose-dependent increase in
membrane lytic activity was observed for wild type and mutant
viruses (Fig. 5A). However, the data derived from the G48C and
L40Q viruses revealed lower membrane disruption activity than
that for wild type virions. Speciﬁc liposome lysis by AdV VI-G48C
was 1.4- and 2.7-fold less than wild type virions at concentrations
of 12.5 and 6.25 mg/ml, respectively. AdV VI-L40Q lytic activity
was more severely attenuated than G48C, in good agreement with
the infectivity data indicating that this virus is less infectious.
As the observed decrease in liposome lysis mediated by
thermally dissociated AdV VI-G48C particles could be attributed
to the partial defect in VI release following heat treatment at
50 1C, we next assessed the lytic activity of the puriﬁed VI114
proteins. We also observed a dose-dependent increase in lytic
activity for each protein VI variant, with the two mutants being
right-shifted compared to wild type (Fig. 5B). The reduction in
membrane lysis for recombinant G48C was similar to that seen
for the heat-disrupted virus, ranging from 1.7- to 4.8-fold at
concentrations of protein from 1.6 to 0.4 mg/ml. L40Q again
exhibited more attenuated lytic activity, with reductions com-
pared to wild type protein between 3.9- to 10-fold over the same
protein concentrations. Together, these results indicate that the
Fig. 5. G48C attenuates protein VI membrane lytic activity. Serial dilutions of
heat-disrupted virus (A) or recombinant protein VI114 (B) at the indicated
concentrations were mixed with liposomes and incubated at 37 1C. Liposome
lysis (Sulfo B release) was monitored with a Tyhpoon Fluorimager. The mean
percentage of speciﬁc lysis7SEM relative to complete lysis in the presence of
Triton X-100 is plotted. Data are from triplicate samples.
Fig. 6. Reduction of disulﬁde bonds partially restores G48C lytic activity. AdVs
(A) or recombinant protein VI (B) were treated with (þ) or without () 10 mM
DTT before being assessed for liposome lysis activity as in Fig. 5.
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mutation is a consequence of both restricted capsid release and
partially defective membrane disrupting activity.
DTT treatment partially restores VI lytic activity
Given the inherent decrease in membrane lytic activity of the
disulﬁde bonded protein VI molecules, we next asked whether
reduction of the disulﬁde bonds could restore membrane lytic
activity to the G48C protein. DTT treatment modestly reduced
membrane lytic activity of wild type and L40Q protein VI perhaps
due to non-speciﬁc or off-target effects (Fig. 6). In contrast, the
membrane lytic activity of heated virions and recombinant
VI114-G48C (Figs. 6A and B, respectively) increased modestly
following incubation with DTT. This small increase in membrane
lytic activity was consistently observed in three independent
experiments. Therefore, we conclude that disulﬁde bond forma-
tion not only restricts release of the membrane lytic protein from
the viral capsid, but also impairs proper interaction with the host
membrane that allows subsequent membrane lytic activity.Discussion
Although our knowledge of endosome penetration by AdV has
steadily improved over the past several years, we still lack a
complete understanding of the structural and biochemical prop-
erties underlying this crucial cell entry step. The VI-G48C mutant
AdV we have described in this study reveals details about proteinVI organization within the AdV particle, as well as advances our
understanding of membrane penetration.
Circular dichroism spectroscopic analysis has revealed that
the N-terminal domain of protein VI (34–114) is 485% a-helix
(Maier et al., 2010) and that an amphipathic a-helical segment
(residues 34–54) contains the majority of membrane lytic activity
(Wiethoff et al., 2005). Structural predictions indicate that
the remaining C-terminal domain is largely disordered. Within
the context of the AdV particle, there is no conclusive data on the
structural organization of the 360 molecules of protein VI.
Biochemical (Matthews and Russell, 1994, 1995) and genetic
(Wodrich et al., 2003) analyses are consistent with a direct
interaction between protein VI and hexon. Additionally, X-ray
crystallography and cryoelectron microscopy reconstructions of
AdV particles assign density within the internal cavity of hexon
trimers to protein VI (Liu et al., 2010; Perez-Berna et al., 2009;
Reddy et al., 2010; Saban et al., 2006; Silvestry et al., 2009). While
putative VI density is observed under every hexon, these struc-
tural techniques depend on icosahedral averaging to generate
high resolution structural data; therefore, it remains unclear what
proportion of hexons are associated with protein VI molecules
and how VI is arranged. The symmetry mismatch (360 copies of
protein VI to 240 hexon trimers) obscures interpretation of the
observed density, as stoichiometry calculations would indicate
1.5 molecules of protein VI per hexon trimer. Thus, the oligomeric
state of protein VI in the virion remains an enigma, as well as its
role in capsid stability and membrane damage. As revealed from
the studies presented here, the formation of intermolecular
disulﬁde bonds in the G48C mutant virus suggests that a sub-
population of individual VI molecules within the particle must be
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disulﬁde bond is approximately 2.02–2.04 A˚ in length (Petersen
et al., 1999). Interestingly, chemical crosslinking (Chatterjee et al.,
1985) and size-exclusion chromatography (Everitt and Philipson,
1974) studies with disrupted virions indicated that a portion of
protein VI molecules in the capsid form dimers, further substan-
tiating our ﬁndings. If protein VI were exclusively dimerized in
the AdV capsid, we would expect nearly all protein VI molecules
to be involved in intermolecular disulﬁde bonds in the G48C
capsid. However, we observed that only 58% dimer formation in
the mutant. This ﬁnding is more consistent with trimers of
protein VI molecules within the particle, a structural organization
that would ideally lead to 66% dimer formation. Alternatively,
protein VI molecules may exist in different oligomeric states
depending on their association with quasiequivalent hexons that
are in four distinct structural positions (i.e. a natural mixture
monomer and dimer).
We did not observe a difference in protein VI incorporation
into the virions during capsid maturation, suggesting that proper
assembly occurs in the presence of VI dimers or that protein VI
dimerization occurs post-assembly. Nevertheless, our studies
clearly demonstrate a diminished ability of AdV bearing the
G48C mutation to damage membranes and to infect cells. It is
currently difﬁcult to determine the relative contribution of
reduced VI release from the capsid and decreased membrane
rupture in the diminished AdV VI-G48C infectivity, but both are
likely to contribute. There is currently no data on the number of
protein VI molecules that must be released in the endosome to
allow rupture and particle escape to the cytoplasm. However, a
complete lack of protein VI exposure as occurs in a hyper-
stabilized temperature sensitive mutant of HAdV type 2 (ts1),
abrogates endosome lysis and infection (Greber et al., 1996;
Weber, 1976). In the case of the AdV VI-G48C mutant, roughly
50% of the protein VI molecules remain capsid associated upon
heating, suggesting that protein VI release in the endosome may
also be defective. In contrast to the ts1mutant, we did not observe
a complete block in infection. Thus, we propose that endosome
penetration requires the release of only a subset (o50%) of
protein VI molecules.
The G48C mutant also showed attenuation in membrane lytic
activity independent of protein VI release. The current model for
VI mediated endosome disruption involves membrane lysis via
induction of positive curvature (Maier et al., 2010). Furthermore,
previous studies have indicated that three tryptophan residues
(minimally) within the N-terminal helical domain insert into the
membrane (Maier et al., 2010; Moyer et al., 2011). Helical wheel
modeling indicates that Gly48 resides on the hydrophobic face of
the amphipathic a-helix (Fig. 1). Based on this structural model,
disulﬁde formation has the propensity to impact proper VI
membrane insertion, as it essentially reduces the molar equiva-
lents of protein VI within endocytic vesicles by half. Maximal lytic
activity of VI molecules would be reduced if dimerization shields
these residues from normal membrane insertion. Furthermore,
monomers of protein VI containing the G48C mutation, in the
absence of disulﬁde bonding, also show modest defects in
membrane lysis. Thus substitution of a larger polar amino acid
at position 48 alone may be sufﬁcient to perturb VI membrane
lytic activity. Glycine residues, due to their small size, confer
conformational ﬂexibility to amphipathic helices that mediate
membrane curvature (Drin et al., 2007). It is possible the G48C
mutation diminishes the ability of protein VI to induce positive
curvature, thereby decreasing lytic activity.
Overall, the work presented here provides important clues to
the organization of protein VI within the AdV capsid and empha-
sizes the role of this capsid protein in cell entry and infection.
Additional structural studies should provide a more mechanisticunderstanding of the effects of the G48C mutation on AdV
infection and protein VI membrane lytic activity.Materials and methods
Cell lines and viruses
A549 (ATCC) and 293b5 cells (Smith et al., 2010) were cultured
in DMEM (Invitrogen) supplemented with 10% FBS. The genera-
tion of wild type and mutant AdVs used in this study have been
previously described and are based on a BAC vector (pAd5-GFPn1)
encoding the HAdV5 genome (Moyer et al., 2011; Wodrich et al.,
2010). A CMV-driven EGFP reporter cassette replacing the E1/E3
region of HAdV5 generates a replication-defective virus in a non-
complementing cell line (e.g. A549). AdVs were grown in com-
plementing 293b5 cells and puriﬁed from cellular lysates by
banding in cesium chloride density gradients, followed by dialysis
into A195 buffer (Evans et al., 2004). Aliquots were ﬂash frozen in
liquid nitrogen and stored at 80 1C. Puriﬁed virus was boiled in
SDS sample buffer 72 mM dithiothreitol (DTT) and analyzed by
SDS-PAGE and immunoblot with a polyclonal antibody to protein
VI. This antibody was generated by immunizing rabbits with a
recombinant version of mature protein VI.
Single-round infection
A549 cells were infected with serial dilutions of wild type or
mutant AdVs in DMEM in black 96-well plates (Corning Inc.) and
incubated for 48 h at 37 1C in 5% CO2. GFP ﬂuorescence intensity
was measured for each well with a Typhoon Fluorimager
(GE Healthcare). Geometric mean ﬂuorescence was plotted as a
function of the input particles/cell. Nonlinear regression analysis
with GraphPad Prism (GraphPad Software Inc, La Jolla, CA) was
used to calculate the dose of virus required for 50% of maximal
infection (ID50) as reported in the text.
AdV plaque assay
293b5 cells plated in 12-well plates were infected with AdV
(0.5 particles/cell) diluted in DMEM for 1 h at 37 1C with rocking.
The media was removed and the cells were washed with PBS.
Cells were overlaid with a mixture of 1.2% Avicel (FMC Corpora-
tion) and EMEM (Lonza Biowhittaker) supplemented with 5% FBS.
The cells were incubated for 72 h at 37 1C. Monolayers were
scanned with a Typhoon Fluorimager and plaques (GFP positive
foci) were enumerated with ImageJ.
Thermostability assay for AdV uncoating
AdV thermostability was assessed using a protocol that is
similar to that previously described (Moyer et al., 2011; Smith
and Nemerow, 2008). Brieﬂy, AdVs (1.5 mg) were heated to 45, 50,
55 or 60 1C for 10 min, loaded onto a 30–80% Histodenz (Sigma)
discontinuous gradient and centrifuged in an SW55ti rotor (Beck-
man Colter) for 1.5 h at 209,000g (ave). Supernatant (top) and band
(interface) fractions were boiled in SDS gel loading buffer contain-
ing 2 mM DTT. SDS-PAGE was followed by immunoblot with a
polyclonal a-protein VI antibody or the monoclonal anti-ﬁber
antibody, 4D2 (NeoMarkers, Lab Vision Corporation, Fremont, CA).
Recombinant VI114 puriﬁcation
A construct encoding residues 34–114 of protein VI with
a N-terminal 6x-histidine tag was cloned into pET15b (EMD
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with site-directed mutagenesis using the primers:
G48C-F: 50-AATTTCTGTTCCACCGTTAAG, G48C-R: 50-GGTGGAA-
CAGAAATTTTTAATG, L40Q-F: 50-GCTGGGGCTCGCAGTGGAGCGGC,
L40Q-R: 50-GCTCCACTGCGAGCCCCAGCTGAAG.
Proteins were expressed in BL21(DE3)-RIPL (Stratagene) cells
grown in Circle Grow media (MP Biomedicals) and induced with
1 mM IPTG. Cells were lysed with Bugbuster Protein Extraction
Reagent (EMD Chemicals) supplemented with 1 mg/ml lysozyme
(Sigma), 20 units/ml Benzonase (Novagen), 150 mM NaCl, EDTA-
free protease inhibitor tablets (Roche), and 10 mM imidazole. The
his-tagged proteins were further puriﬁed by afﬁnity chromato-
graphy on Talon Cobalt resin (Clontech) and exchanged into
50 mM Tris–HCl/100 mM NaCl pH 8.0 by gel ﬁltration on a HiLoad
Superdex 16/60 S75 column using an AKTApuriﬁer (GE Health-
care). Puriﬁed protein was boiled in SDS sample buffer 72 mM
DTT and analyzed on SDS-PAGE gels stained with Simply Blue
(Invitrogen).
Determination of VI membrane lytic activity in vitro
Lipid solutions in chloroform [1-palmitoyl,2-oleoylphosphati-
dylcholine (POPC) and 1-palmitoyl,2-oleoylphosphatidylserine
(POPS)] were purchased from Avanti Polar Lipids. The lipids (75
POPC:25 POPS mol%, 1 mg total lipid) were dried under nitrogen
and resuspended in 1 mL of 100 mM sulforhodamine B (SulfoB,
Molecular Probes) dissolved in 25 mM HEPES, 150 mM NaCl
buffer pH 7.5 (HBS). Uniform vesicles were generated by extru-
sion through 0.2 mm polycarbonate ﬁlters. Free dye was removed
using a PD-10 desalting column (GE Healthcare) equilibrated
with HBS.
Partial disassembly of AdV particles was achieved by heating
to 50 1C to release protein VI from the interior of the virion. Serial
dilutions of virus or recombinant VI114 protein in HBS at the
concentrations indicated in Fig. 5 were mixed with liposomes
(10 ml protein, 1 ml liposomes, 39 ml HBS). The samples were
incubated at 37 1C for 20 min with rocking and SulfoB release
was measured with a Typhoon Fluorimager at an excitation
wavelength of 532 nm. Full liposome lysis was achieved by
adding Triton X-100 to 0.5%. Speciﬁc liposome lysis was calcu-
lated with the following formula:
%SulfoB released¼ 100 ½ðFprotFbkgdÞ=ðFdetFbkgdÞ
where Fprot is the ﬂuorescence intensity in the presence of AdV or
VI114 protein, Fbkgd is the background ﬂuorescence, and Fdet is the
ﬂuorescence intensity in the presence of 0.5% Triton X-100.
The membrane lytic activity of DTT-treated viruses or VI114
recombinant protein was assayed by pre-incubation of virus
(315 mg/ml) or protein (225 mg/ml) for 1 h or 30 min, respectively,
at room temperature in the presence or absence of 10 mM DTT.
Viruses were then heated to 50 1C to allow protein VI release.
Samples were diluted to 25 mg/ml (AdV) or 1 mg/ml (VI114 protein)
and processed in liposome lysis assays as described above.Acknowledgments
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